Enovis Official Partner of F.C. Como Women: a partnership built on cutting-edge medical technology to enhance athlete performance and care
F.C. Como Women is proud to announce a new three-year partnership with Enovis™, a global MedTech company and leader in developing clinically differentiated medical technologies for the prevention, enhancement, and recovery of athletes.
This collaboration aims to integrate innovation, technology, and care into the players’ athletic journey, with Enovis providing support to the Club’s performance and physiotherapy areas through the 2027/2028 season. The agreement reflects a shared vision focused on prevention, functional rehabilitation, and load optimization — all in the service of player health and team performance.
Technology and innovation in the service of professional sport
Through its internationally recognized brands, including Chattanooga and Compex®, Enovis has established itself over the years as a leader in the medical and rehabilitation sector. Its approach is built on continuous innovation, patient-centered care, and the integration of scientific research with applied technology.
With over 7,000 employees worldwide and a strong presence in sports medicine, this partnership will allow F.C. Como Women to benefit from state-of-the-art devices for integrated injury management, improved recovery times, and prevention — promoting a positive and sustainable impact on player well-being.
Voices of the partnership
“We are very excited to start this partnership with a company like Enovis, a global benchmark in medical technology applied to sport and beyond,” said Nicola Verdun, CEO of F.C. Como Women.
“Our goal is to provide our players with an increasingly professional and complete environment, where prevention, recovery, and athlete care are central. This partnership will allow us to create dedicated, personalized programs for each player. Enovis represents the ideal partner for us to take another step forward on this path.”
“This collaboration stems from a shared vision and a common project that brings together two organizations driven by the same ambition: to raise the standards of performance and well-being through innovation and expertise.
With F.C. Como Women, we have found a partner that looks to the future with the same mindset — investing in prevention, technology, and personalized programs to enhance every single athlete. Enovis is proud to offer the Club its know-how and cutting-edge solutions to help build, together, a virtuous model in which care, science, and sport come together for the benefit of health and performance,” said Andrea Faso, General Manager of Enovis Italy.
About F.C. Como Women
F.C. Como Women is one of the few professional and independently owned clubs in Italian women’s football, currently competing in Serie A Women. In March 2024, the entry of Mercury 13, followed by the American investment fund Avenue Capital, marked a decisive turning point for the Club — leading to a complete rebranding, the renewal of both technical and corporate staff, and the creation of a competitive squad.
About Enovis
Enovis™ is a global MedTech company committed to developing clinically advanced solutions that improve people’s quality of life.
Through its internationally recognized brands such as Chattanooga®, Compex®, DonJoy®, and Aircast®, Enovis provides innovative technologies and services to surgeons, physiotherapists, and rehabilitation and sports professionals worldwide.
